Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Faron Pharmaceuticals
Faron Pharmaceuticals
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Regulatory
New patent protects the intravenous use of interferon-beta in a novel formulation
Faron has developed the first intravenous formulation of IFN-beta to enable the treatment of vascular leakage in lungs and other central organs
Manufacturing
Abzena to manufacture therapeutic antibody for Faron
Clevegen is a novel therapeutic antibody being developed by Faron to reduce immune suppression in cancer
Research & Development
Faron strengthens executive team by appointing new Medical Director
He will play a central role in expanding the Finnish firm's clinical programmes of drug candidates
Research & Development
Faron links up with Selexis to progress development of cancer antibody
Under the agreement, Faron will have access to the Selexis SUREtechnology platform and SURE CHO-M cell line
Ingredients
Rentschler to manufacture Traumakine for Faron
German contract manufacturer first produced product in 1980s
Subscribe now